Market OverviewThe global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period.
MedPage Today on MSN
'Most Compelling' Data Yet for Metastasis-Directed Therapy in Prostate Cancer
But an association with improved overall survival failed to reach statistical significance ...
An electronic health record-integrated AI agent developed to improve patient education on prostate cancer with personalized ...
Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...
Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...
PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment ...
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
SurvivorNet on MSN
Prostate cancer screening: Get the actual guidelines for men, why doctors don’t agree, and what you need to know to make decisions
A new Super Bowl Sunday ad starring legendary NFL players aims to boost prostate cancer awareness. Using humor and famous ...
A cancer specialist explains the subtle warning signs that are easy to dismiss ...
Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...
Black men face the highest rate of prostate cancer diagnosis and death in the US, with many diagnosed at later stages due to lack of screening and prevention legislation, resulting in preventable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results